Cardiomyopathy Subtype | Tertiary care centre | Systematic review | ||
Assessed, n (%) | Affected, n (%) | Assessed, n (%) | Affected, n (%) | |
ICM | 3 | 193 | ||
Inotrope | 3 (100) | 0 | 0 | NR |
LVAD | 0 | 0 | NR | |
OHT listing | 0 | 0 | NR | |
VT/VF | 0 | 193 (100) | 19 (10) | |
Maternal death | 0 | 193 (100) | 11 (6) | |
Composite MACE | 0 | 193 (100) | 108 (56) | |
PPCM | 10 | 41 069 | ||
Inotrope | 10 (100) | 2 (20) | 240 (0.6) | 2 (0.8) |
LVAD | 0 | 35 237 (86) | 541 (1.5) | |
OHT listing | 0 | 661 (1.6) | 29 (4.4) | |
VT/VF | 1 (10) | 1132 (2.8) | 217 (19) | |
Maternal death | 1 (10) | 40 780 (99) | 612 (1.5) | |
Composite MACE | 4 (40) | 40 826 (99) | 4972 (12) | |
NICM | 19 | 353 | ||
Inotrope | 19 (100) | 2 (11) | 0 | NR |
LVAD | 0 | 0 | NR | |
OHT listing | 0 | 0 | NR | |
VT/VF | 0 | 222 (63) | 34 (15) | |
Maternal death | 0 | 304 (86) | 7 (2) | |
Composite MACE | 2 (11) | 0 | NR |
ICM, ischaemic cardiomyopathy; LVAD, left ventricular assist device; MACE, major adverse cardiovascular event; NICM, non-ischaemic cardiomyopathy; NR, not reported; OHT, orthotopic heart transplant; PPCM, peripartum cardiomyopathy; VT/VF, ventricular tachycardia/ventricular fibrillation.